Trial Details
COMPLETEDBasic Information
| Clinical ID | c54 |
|---|---|
| Identifier | NCT07263464 |
| Trial Title | The Association Between TNFSF4 Polymorphism and CD |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Inflammatory Bowel Disease (Crohn's Disease and Ulcerative Colitis)|Polymorphism, Single Nucleotide|Ustekinumab |
| Interventions | BIOLOGICAL: Ustekinumab - Standard Dosage |
Participant Information
| Sponsor | Second Affiliated Hospital of Wenzhou Medical University |
|---|---|
| City | Zhejiang |
| Country/Region | China |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | OBSERVATIONAL |
|---|---|
| Phase | NULL |
Time Information
| Start Date | 2018-01-01 |
|---|---|
| Primary Completion Date | 2025-05-31 |
| Completion Date | 2025-05-31 |